Reporting owner · CIK 0001448914

Heffernan Michael Thomas

Visual SEC Form 4 history across 2 companies, 8 transactions and 2 filings.

DIRTrevi Therapeutics, Inc.
Open-market mix
Latest filingSep 17, 2026, 08:55 PM
Filings2Form 4 records
Buying$00 purchases
Selling$594.2K3 sales
Net value−$594.2KBuys minus sells
Companies22 securities
Most recentSep 15, 2026exercise

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Feb 253Sep 26

Net value flow

Buys minus sells

Feb 25
$0
Sep 26
−$594.2K

Transaction texture

Ownership and ticket size

Average P/S size$198.1K
Median P/S size$276.5K
Direct8
Indirect0
Sep 15, 2026exercise

Filing-only signals

Deterministic matches in this insider's history

Direct Ownershipfiling-context1

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Trevi Therapeutics, Inc. on Sep 15, 2026 valued at $316,166.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Trevi Therapeutics, Inc. on Sep 15, 2026 valued at $316,166.

Review SEC filing

Associated companies

Visual map of known reporting history

TRVITrevi Therapeutics, Inc.7 transactions · latest Sep 17, 2026, 08:55 PMCOLLCOLLEGIUM PHARMACEUTICAL, INC1 transactions · latest Feb 12, 2025, 09:10 PM

Latest insider transactions

Form 4 filings from available history. Click any column to sort; click it again to flip the order.

Heffernan Michael Thomas transactions
IDTickerInsiderRoleTypeSharesValueCodeFiledTrans date
#224342TRVIHeffernan Michael Thomas
DIR
exercise10b5-121.0k$0M09/1709/15
#224341TRVIHeffernan Michael Thomas
DIR
exercise10b5-118.4k$0M09/1709/15
#224339TRVIHeffernan Michael Thomas
DIR
sale10b5-120.9k-$31.6MS09/1709/15
#224338TRVIHeffernan Michael Thomas
DIR
exercise10b5-121.0k$7.01MM09/1709/15
#224337TRVIHeffernan Michael Thomas
DIR
sale10b5-1100-$158kS09/1709/15
#224336TRVIHeffernan Michael Thomas
DIR
sale10b5-118.3k-$27.6MS09/1709/15
#224335TRVIHeffernan Michael Thomas
DIR
exercise10b5-118.4k$5.59MM09/1709/15
#92705COLLHeffernan Michael Thomas
DIR
grant4.82k$0A02/12/202502/10/2025

Heffernan Michael Thomas Insider Activity FAQ

SEC Form 4 context

Who is Heffernan Michael Thomas?

Heffernan Michael Thomas is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001448914.

Which companies has Heffernan Michael Thomas reported transactions for?

Trevi Therapeutics, Inc., COLLEGIUM PHARMACEUTICAL, INC

When was Heffernan Michael Thomas's latest insider buy?

No open-market insider purchase is available for this period.

When was Heffernan Michael Thomas's latest insider sale?

sale at Trevi Therapeutics, Inc. on Sep 15, 2026 valued at $316,166.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.